Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2 1

Status

Completed 3Withdrawn 1

Sponsor Class

INDUSTRY 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Dermatologic 3

Conditions

Lymphoma, T-Cell, Cutaneous 5Lymphoma 5Lymphoma, T-Cell, Peripheral 4Leukemia, Lymphocytic, Chronic, B-Cell 4Sezary Syndrome 3Mycosis Fungoides 3Melanoma 3Lymphoma, Follicular 3Carcinoma, Ovarian Epithelial 3Breast Neoplasms 3Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell 2Leukemia 2Kidney Neoplasms 2Fallopian Tube Neoplasms 2Drug-Related Side Effects and Adverse Reactions 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms, Male 2Waldenstrom Macroglobulinemia 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Pancreatic Neoplasms 1Neoplasms by Histologic Type 1Neoplasm Metastasis 1Mastocytosis, Systemic 1Lymphoproliferative Disorders 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1

Interventions

Peripheral Blood Stem Cell Transplantation 28fludarabine phosphate 25Cyclophosphamide 19Cyclosporine 18Whole-Body Irradiation 17Mycophenolic Acid 17Tacrolimus 15Busulfan 13Antilymphocyte Serum 11Methotrexate 10Methylprednisolone 8Filgrastim 8Vorinostat 7Radiotherapy 7Flow Cytometry 7Etoposide 7Bortezomib 6Psychiatric Rehabilitation 5Everolimus 5Dexamethasone 5Bexarotene 5Alemtuzumab 5Transplantation 4Therapeutics 4Polymerase Chain Reaction 4Panobinostat 4Lenalidomide 4Gemcitabine 4Carboplatin 4Calcium Dobesilate 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Sezary Syndrome × denileukin diftitox × Clear all
NCT00006345 2013-05-30

Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma

National Cancer Institute (NCI)

Phase 2 Completed
DermatologicLymphoid

Lymphoma, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Drug-Related Side Effects and Adverse Reactions

NCT00050999 2008-03-05

Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients

Eisai Inc.

Phase 4 Completed
195 enrolled
DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

NCT00051012 2008-03-05

Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients

Eisai Inc.

Phase 4 Completed
86 enrolled
DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡